DrugDashboards

Lidocaine Hydrochloride and Hydrocortisone Acetate

Lidocaine Hydrochloride and Hydrocortisone Acetate · LIDOCAINE HYDROCHLORIDE 30 mg/g; HYDROCORTISONE ACETATE 5 mg/g · Cream · Rectal · Seton Pharmaceuticals

NDC 13925-0165-20 · 20 TUBE in 1 KIT / 7 g in 1 TUBE · UNAPPROVED DRUG OTHER · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has fallen 46% in a year, to $91.19 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$100.00$200.00Nov 2013Jul 2025$91.19
17 price points · per EA · last surveyed Jul 23, 2025Source: CMS NADAC

Medicaid spend (2024)

$8,474
33 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for lidocaine hydrochloride and hydrocortisone acetate (other) in the next 90 days

price up 21% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lidocaine Hydrochloride and Hydrocortisone Acetate (Cream)

LabelerStrengthFirst seenLast seen
Seton PharmaceuticalsLIDOCAINE HYDROCHLORIDE 30 mg/g; HYDROCORTISONE ACETATE 5 mg/gAug 26, 2026Sep 3, 2026
Seton PharmaceuticalsLIDOCAINE HYDROCHLORIDE 30 mg/g; HYDROCORTISONE ACETATE 10 mg/gAug 26, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCLIDOCAINE HYDROCHLORIDE 30 mg/g; HYDROCORTISONE ACETATE 5 mg/gAug 26, 2026Sep 2, 2026
Seton PharmaceuticalsLIDOCAINE HYDROCHLORIDE 5 mg/g; HYDROCORTISONE ACETATE 30 mg/gJul 22, 2026Aug 21, 2026
Seton PharmaceuticalsLIDOCAINE HYDROCHLORIDE 10 mg/g; HYDROCORTISONE ACETATE 30 mg/gJul 22, 2026Aug 19, 2026
Westminster Pharmaceuticals, LLCLIDOCAINE HYDROCHLORIDE 5 mg/g; HYDROCORTISONE ACETATE 30 mg/gJul 22, 2026Aug 19, 2026
Seton PharmaceuticalsHYDROCORTISONE ACETATE 5 mg/g; LIDOCAINE HYDROCHLORIDE 30 mg/gJul 15, 2026Jul 19, 2026
Seton PharmaceuticalsHYDROCORTISONE ACETATE 10 mg/g; LIDOCAINE HYDROCHLORIDE 30 mg/gJul 15, 2026Jul 15, 2026
Westminster Pharmaceuticals, LLCHYDROCORTISONE ACETATE 5 mg/g; LIDOCAINE HYDROCHLORIDE 30 mg/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride and Hydrocortisone Acetate — NDC 13925-0165-20," retrieved September 3, 2026, https://drugdashboards.com/drug/13925016520.

Free to cite with attribution — see how the data is put together.